| Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ... Nature medicine 27 (4), 717-726, 2021 | 1015 | 2021 |
| SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses JS Turner, JA O’Halloran, E Kalaidina, W Kim, AJ Schmitz, JQ Zhou, T Lei, ... Nature 596 (7870), 109-113, 2021 | 767 | 2021 |
| SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans JS Turner, W Kim, E Kalaidina, CW Goss, AM Rauseo, AJ Schmitz, ... Nature 595 (7867), 421-425, 2021 | 597 | 2021 |
| Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study P Deepak, W Kim, MA Paley, M Yang, AB Carvidi, EG Demissie, ... Annals of internal medicine 174 (11), 1572-1585, 2021 | 452* | 2021 |
| Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm PA Mudd, JC Crawford, JS Turner, A Souquette, D Reynolds, D Bender, ... Science advances 6 (50), eabe3024, 2020 | 276* | 2020 |
| Germinal centre-driven maturation of B cell response to mRNA vaccination W Kim, JQ Zhou, SC Horvath, AJ Schmitz, AJ Sturtz, T Lei, Z Liu, ... Nature 604 (7904), 141-145, 2022 | 267 | 2022 |
| SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans PA Mudd, AA Minervina, MV Pogorelyy, JS Turner, W Kim, E Kalaidina, ... Cell 185 (4), 603-613. e15, 2022 | 255 | 2022 |
| Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection L Ma, SK Sahu, M Cano, V Kuppuswamy, J Bajwa, JN McPhatter, A Pine, ... Science immunology 6 (59), eabh2259, 2021 | 203 | 2021 |
| Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19 D Scozzi, M Cano, L Ma, D Zhou, JH Zhu, JA O’Halloran, C Goss, ... JCI insight 6 (4), 2021 | 181 | 2021 |
| CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14 BK Patterson, H Seethamraju, K Dhody, MJ Corley, K Kazempour, ... International Journal of Infectious Diseases 103, 25-32, 2021 | 137 | 2021 |
| SARS-CoV-2 Omicron boosting induces de novo B cell response in humans WB Alsoussi, SK Malladi, JQ Zhou, Z Liu, B Ying, W Kim, AJ Schmitz, T Lei, ... Nature 617 (7961), 592-598, 2023 | 111 | 2023 |
| Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity M Sindelar, E Stancliffe, M Schwaiger-Haber, DS Anbukumar, ... Cell Reports Medicine 2 (8), 2021 | 107 | 2021 |
| Increased platelet reactivity in HIV-1–infected patients receiving abacavir-containing antiretroviral therapy CS Satchell, JA O’Halloran, AG Cotter, AJ Peace, EF O’Connor, ... Journal of Infectious Diseases 204 (8), 1202-1210, 2011 | 107 | 2011 |
| Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study C Mejia-Chew, JA O'Halloran, MA Olsen, D Stwalley, R Kronen, C Lin, ... The Lancet Infectious Diseases 19 (12), 1336-1344, 2019 | 103 | 2019 |
| Abatacept, cenicriviroc, or infliximab for treatment of adults hospitalized with COVID-19 pneumonia: a randomized clinical trial JA O’Halloran, ER Ko, KJ Anstrom, E Kedar, MW McCarthy, RA Panettieri, ... Jama 330 (4), 328-339, 2023 | 75* | 2023 |
| The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV‐1 infection JA O'Halloran, E Dunne, MMP Gurwith, JS Lambert, GJ Sheehan, ... HIV medicine 16 (10), 608-619, 2015 | 75 | 2015 |
| A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants AJ Schmitz, JS Turner, Z Liu, JQ Zhou, ID Aziati, RE Chen, A Joshi, ... Immunity 54 (9), 2159-2166. e6, 2021 | 73* | 2021 |
| Efficacy, safety, and immunogenicity of a booster regimen of Ad26. COV2. S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled … K Hardt, A Vandebosch, J Sadoff, M Le Gars, C Truyers, D Lowson, ... The Lancet Infectious Diseases 22 (12), 1703-1715, 2022 | 68 | 2022 |
| Cryptococcosis today: it is not all about HIV infection JA O’Halloran, WG Powderly, A Spec Current Clinical Microbiology Reports 4, 88-95, 2017 | 61 | 2017 |
| Integrase strand transfer inhibitors are associated with incident diabetes mellitus in people with human immunodeficiency virus JA O’Halloran, J Sahrmann, L Parra-Rodriguez, DT Vo, AM Butler, ... Clinical Infectious Diseases 75 (12), 2060-2065, 2022 | 54 | 2022 |
